BioIntelliSense, Inc logo

BioIntelliSense, Inc

A New Era of Continuous Health Monitoring and Clinical Intelligence

106 employees · est. 2018 · Denver, United States

VS
NimbleHeart logo

NimbleHeart

NimbleHeart Physiotrace Smart is the FDA-approved wearable and easily reusable Exercise ECG Monitor for preventive care

7 employees · est. 2013 · Sunnyvale, United States

NimbleHeart is the older company (2018 vs 2013); BioIntelliSense, Inc is the larger of the two.

Side-by-Side Comparison

BioIntelliSense, Inc NimbleHeart
Founded
2018 2013 older
Headquarters
Denver, United States Sunnyvale, United States
Employees
106 larger 7
Industry
Biotechnology, Health Care, Medical Devices Health Care, Health and Wellness, Manufacturing
Funding Stage
Series B Seed
Total Funding
$84.80M $3.24M
Funding Rounds
4 6
Services
Not tracked yet Early Detection of Cardiac Events, Remote Cardiac Screening, Exercise ECG Monitoring
Target Customers
Not tracked yet Individuals at Risk of Cardiac Events, Patients with Cardiac Conditions, Healthcare Providers, Covid-19 Patients with Symptoms
Taxonomy
Remote Patient Monitoring, Clinical Intelligence, Health Monitoring, Continuous Monitoring, Data-as-a-Service, Medical-grade Devices, FDA-cleared Technology, Wearable Technology, Physiological Biometrics, Remote Care, Advanced Analytics, Healthcare Innovation, Patient Trending, Early Detection, Medical Data Services FDA-approved, Wearable ECG, Cardiac Monitor, Heart Health, Preventive Care, Medical Device, Internet-connected, Wireless Technology, Cardiac Monitoring, Real-time Analysis, Multidisciplinary Team, Home Healthcare, Healthtech, FDA Approval Process, Remote Patient Monitoring
Website
biointellisense.com nimbleheart.com
BioIntelliSense, Inc logo

About BioIntelliSense, Inc

BioIntelliSense, Inc is a biotechnology startup founded in 2018 based in the United States. The company's slogan, "A New Era of Continuous Health Monitoring and Clinical Intelligence", aligns with its mission to revolutionize Remote Patient Monitoring (RPM). BioIntelliSense offers a medical-grade Da...

NimbleHeart logo

About NimbleHeart

NimbleHeart, founded in 2012, has positioned itself at the forefront of cardiac monitoring technology with its pioneering FDA-approved exercise wearable ECG cardiac monitor. As the first device of its kind, NimbleHeart promotes heart health through both real-time and post-session monitoring, aimed s...

We will tell you when either one moves

BounceWatch watches BioIntelliSense, Inc and NimbleHeart for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioIntelliSense, Inc and NimbleHeart — by email.

Frequently Asked Questions

BioIntelliSense, Inc — A New Era of Continuous Health Monitoring and Clinical Intelligence . NimbleHeart — NimbleHeart Physiotrace Smart is the FDA-approved wearable and easily reusable Exercise ECG Monitor for preventive care. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioIntelliSense, Inc has raised $84.80M while NimbleHeart has raised $3.24M.
BioIntelliSense, Inc and NimbleHeart operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioIntelliSense, Inc with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at BioIntelliSense, Inc on 12 Sep 2024, and NimbleHeart on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy